Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT00433927
Title 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors PD Dr. med. Volker Heinemann,Merck KGaA, Darmstadt, Germany
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.